Skip to main content
Veterinary Medicines

Nobilis Paramyxo P201 Emulsion for injection

Authorised
  • Pigeon paramyxovirus 1, strain P201, Inactivated

Product identification

Medicine name:
Nobilis Paramyxo P201 Emulsion for injection
Active substance:
  • Pigeon paramyxovirus 1, strain P201, Inactivated
Target species:
  • Pigeon
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Pigeon paramyxovirus 1, strain P201, Inactivated
    2.77
    log10 haemagglutination inhibiting unit(s)
    /
    0.25
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pigeon
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01EA01
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • (ID1): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 20 millilitre(s) (20 millilitre(s))
  • (ID2): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 50 millilitre(s) (50 millilitre(s))
  • (ID3): 1 Box with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s) (250 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Le Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 817/02/120748
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0219/001
Concerned member states:
  • Belgium
  • Denmark
  • Estonia
  • France
  • Greece
  • Italy
  • Lithuania
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."